Study on the Efficacy of LAS41005 Compared to Placebo and to LAS106521 in the Treatment of Actinic Keratosis Grade I to II

Trial Profile

Study on the Efficacy of LAS41005 Compared to Placebo and to LAS106521 in the Treatment of Actinic Keratosis Grade I to II

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jul 2015

At a glance

  • Drugs Fluorouracil/salicylic-acid (Primary) ; LAS 106521
  • Indications Actinic keratosis; Skin cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Almirall S.A.
  • Most Recent Events

    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record, EudraCT2007-003889-18).
    • 05 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top